- Business Wire•3 days ago
Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Spectrum Pharmaceuticals, Inc. and certain of its officers and directors made false and misleading statements and/or omissions in violation of Sections 10 and 20 of the Securities Exchange Act of 1934.
- Business Wire•4 days agoGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Spectrum Pharmaceuticals, Inc. Investors and Encourages Investors to Contact the Firm
Glancy Prongay & Murray LLP announces that a class action lawsuit has been filed on behalf of investors who purchased Spectrum Pharmaceuticals, Inc. securities between February 28, 2013 and September 16, 2016, inclusive .
- Marketwired•4 days agoINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 21, 2016 -- SPPI
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Spectrum Pharmaceuticals, Inc. between December 16, 2015......
Spectrum Pharmaceuticals, Inc. (SPPI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||3.80 x 500|
|Ask||4.90 x 7000|
|Day's Range||3.92 - 4.00|
|52wk Range||3.90 - 7.74|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-4.59|
|Avg Vol (3m)||842,195|
|Dividend & Yield||0.00 (0.00%)|